Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
Topol EJ, Easton JD, Amarenco P, Califf R, Harrington R, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Willerson JT, Chan R, Samuels R, Ilson B, Granett J.
Topol EJ, et al.
Am Heart J. 2000 Jun;139(6):927-33. doi: 10.1067/mhj.2000.105107.
Am Heart J. 2000.
PMID: 10827369
Clinical Trial.